Loading lessons…
Loading lessons…
Curated lessons across 8 learning paths — from first concepts to trial summaries and practical protocols. Pick your level, follow the curriculum, and build real understanding.
Where are you starting?
Choose a learning path below or search the library. Progress saves in your browser.
Prefer timeline chaos? Peptide X Quiz · Literacy certify
Pick a track — progress rings update as you complete lessons.
117 lessons
10mTwo antibodies that block the myostatin/activin pathway are being tested alongside GLP-1 drugs to protect lean mass. Bimagrumab's phase 2 BELIEVE trial is published in Nature Medicine. Apitegromab is FDA-approved, but only for spinal muscular atrophy. Neither is a peptide or a pill.
14mOn October 28, 2026, HHS said it will not take enforcement action against qualifying 503A compounding for six peptides while FDA rulemaking continues. That is not FDA approval and not a bulks-list addition. This explainer maps the policy in plain language.
10mThe collagen powder in a grocery store and the vial labeled "research use only" share one word and almost nothing else. This guide explains what each one is, how each is regulated, what the human evidence shows for collagen on skin, joints and bone, and where the copper peptide GHK-Cu fits.
7mThe question arrives at the front desk first. Here is a three-tier script that answers it honestly, cites what exists, and never turns into a claim or a referral to a vendor.
8mEnamel matrix derivative and rhPDGF-BB are FDA-approved devices with decades of trials. BPC-157 and TB-500 have one rat study each in periodontitis. Here is the whole picture, with sources.
9mMost peptide stigma is not a single hazard. It is three different risks that clinics mash together. Separate them and the conversation with counsel, pharmacy, and medical directors gets shorter.
8mIf your team cannot state the regulatory status of each compound in one clean sentence, the menu is not ready. Here is the three-band model clinics use before counsel finishes the memo.
7mVendor PDFs are not primary sources. Here is the order clinics should read FDA and state board pages so status sheets survive the first counsel review.
12mA goal-by-goal map of the peptides people ask about most, scored on human evidence and regulatory status. The only ones with strong evidence are approved drugs; most of the rest are animal data. No vendors, no dosing.
10mAdding peptides to a med spa is a licensing, sourcing and documentation problem before it is a marketing one. Here is the operational order: prescriber, pharmacy, regulatory status by compound, consent, and a way to track what patients actually do between visits.
11mNo peptide is FDA-approved for building muscle in healthy adults. Here is what the human trials actually measured for growth hormone secretagogues, IGF-1 analogs, MOTS-c and the GLP-1 drugs, where each sits on the evidence ladder, and what regulators and anti-doping rules say.
12mThe only peptides with large controlled trials for weight loss are the GLP-1 class: semaglutide, tirzepatide, and the oral options approved in 2025 and 2026. Retatrutide is next but still investigational. Here's how they work, what the trials showed, and how to access them through a licensed clinician.
10mPeptides are short chains of amino acids that act as messengers in the body. Some are FDA-approved medicines like insulin and the GLP-1 drugs. Many sold online are unapproved research chemicals. Here's the plain-language version.
9mA warm hour in a carry-on can matter. Learn cold-chain basics for refrigerated peptides, travel logging, and when to talk with your pharmacist or clinician.
6mAdamax is marketed as a modified Semax. Semax has decades of mostly Russian research. Adamax has essentially none in the published literature. Here's the honest comparison.
8mSS-31 and MOTS-c dominate mitochondrial peptide search. This list ranks the PeptIQ guides that answer dosage, timing, and stack questions without the forum noise.
8mKLOW is a top PeptIQ page and a top search query. This guide ranks blend options, explains GLOW, and points to the deep dosing pages for each component.
7mThe panel backed six peptide nominations but not Emideltide. Here is why evidence and identity questions mattered, and what the result means for people following sleep peptides.
7mPCAC recommended BPC-157, KPV, TB-500, MOTS-c, Semax, and Epitalon for 503A compounding. The unresolved fight is what happens while FDA completes rulemaking.
8mThe loudest peptide stories are moving at different speeds. PCAC recommendations await FDA action, oral GLP-1 access is real, and the next obesity programs still have filing or review milestones ahead.
10mMost BPC-157 dose threads treat forum tables as fact. This guide separates published animal and limited human data from observational ranges people log, without turning either into a protocol.
10mTB-500 threads collapse a fragment, a parent peptide, and forum loading weeks into one chart. The papers are more specific, and the human dosing story is thinner than the marketing.
9mThymosin alpha-1 has a thicker clinical literature than most research-vial peptides. The milligram figures in those papers still belong to study and labeled-product contexts, not an unlabeled cake.
8mCopper peptide chemistry is getting more interesting because the newest diabetic wound work tries to solve glucose, hypoxia, and infection in the same system.
8mMOTS-c is moving beyond the vague mitochondrial hype cycle. The newest data suggests it may participate in membrane repair, which changes the recovery conversation.
11mMid-40s and new to peptides? This guide explains how beginners typically choose a conservative first protocol using goals, compound class, published ranges, and tracking — without inventing a prescription.
10mDry powder vs mixed liquid changes everything — concentration, storage, and beyond-use timing. This guide explains lyophilized vs reconstituted peptides and what people mean by constituted vs non.
12mReta plus Tesa is one of the most asked stack questions in 2026. This guide explains why people combine metabolic and visceral-fat peptides, what to track, and why same-syringe mixing is usually avoided.
11mA 10 mg Selank vial looks simple until you mix the wrong diluent volume or chase a Sealink listing. This guide covers BAC reconstitution math, route context, and tracking habits — educational only, not medical advice.
8mThe clearest signal in today's peptide research is not one molecule. It is the pattern: recovery peptides, metabolic peptides, collagen support, and mitochondrial tools all need tighter tracking.
8mPeople searching how to reconstitute eloralintide usually want a retatrutide-style BAC water chart. Here's the honest version — clinical weekly product vs unverified research powder.
7mWeekly amylin agonists are not MOTS-c. Here's when to inject eloralintide for tolerability — dose-day meals, evening vs morning, and what to log.
8mBoth hit amylin biology. One is Lilly's Phase 3 monotherapy / combo candidate. The other is the amylin half of CagriSema. Here's a clear comparison for people following the next wave of obesity peptides.
6mMacupatide is the Lilly code name beside eloralintide that most people skip. This beginner guide explains what it is — and what not to invent about dosing yet.
9mMOTS-c looks interesting because it can push metabolism in the right direction and still pull repair in the wrong one. The new data are a reminder that pathway activation and tissue healing are not the same thing.
8mA 2025 review makes the same point the peptide world keeps avoiding: some compounds have real human data, and many popular names still do not.
Appetite control is useful only if it does not turn into under-eating. Track the right signals early so the scale does not hide the real tradeoffs.
9mThe GH-IGF1 axis keeps showing up in peptide medicine because it links visceral fat, recovery, and lean mass. The trick is separating the clinical signal from the wellness noise.
9mPeptides are not only treatment candidates anymore. New constrained ligands may help doctors see the tumor microenvironment more clearly, which changes how researchers think about diagnostics, targeting, and drug design.
9mMOTS-C sits at the intersection of mitochondrial signaling, metabolism, and longevity. July 2026 put it back in the spotlight for a reason.
8mRegulation does not settle the peptide debate by itself. It forces clearer questions about sourcing, safety, evidence, and who is responsible when claims move faster than data.
9mHealthy aging is not a slogan. It is a measurable question about inflammation, tissue repair, metabolic control, and whether a peptide has human data behind it.
10mOrthopaedics is paying closer attention to peptides because the field keeps running into the same problem: recovery is biology, but biology still needs evidence before it becomes a protocol.
9mSports medicine keeps pulling peptides into the conversation because recovery pressure is real. The hard part is separating promising biology from weak evidence, gray-market hype, and antidoping risk.
8mMOTS-c is showing up in cardiac stress research. A new rat-heart study points toward mitochondrial bioenergetics, mtDNA integrity, and post-ischemic recovery.
8mMOTS-c is moving beyond generic energy claims. New research points toward mitochondrial stress response, lung inflammation, and cardiac reperfusion biology.
8mThe next metabolic peptide wave is not just stronger GLP-1 dosing. Amylin, GIP, glucagon, and combination protocols are changing what serious tracking should include.
8mMOTS-c is moving beyond the generic energy peptide conversation. New 2026 research connects mitochondrial-derived peptides with atrial fibrosis, inflammation, and heart rhythm biology.
GLP-1 peptides are changing the bariatric surgery conversation. The practical lesson is not self-managing around surgery. It is better tracking, clearer handoffs, and coordinated medical planning.
8mGHK-Cu is moving beyond skin-care hype into a controlled wound-healing study. Here is how to read the Phase 2 trial without overclaiming the result.
8mMOTS-c is one of the most interesting mitochondrial peptides in 2026 because the question is finally shifting from mechanism to human outcomes.
7mThe biggest peptide trend in 2026 may not be a molecule. It may be oversight, sourcing quality, and the ability to separate evidence from marketing.
7mAMA and FDA updates make one thing clear: peptide interest is moving faster than human evidence, dosing standards, and product-quality controls. Use this checklist before trusting a vial.
9mSemax is an ACTH-derived peptide that upregulates BDNF and supports neuroprotection. Here's what the research actually shows — and how to track your cognitive protocol.
8mA new ECRI and ISMP warning says popular wellness peptides are being marketed faster than the evidence can support. Here is how to separate compound science from product risk.
8mHealth Canada's 2026 public advisory names unauthorized injectable peptides sold online and explains why product quality, legal status, and medical supervision matter.
8mA new sports medicine review puts injury-recovery peptides in context. Some mechanisms are promising, but human evidence, safety data, and regulatory status still matter.
7mEDS changes the safety conversation around peptides. GHK-Cu, BPC-157, and TB-500 are discussed for tissue support, but EDS plus cardiac history should stay clinician-led.
8mYou got your first peptide vials and now you are staring at two bottles of powder and a box of needles. Here is exactly how to mix BPC-157 and TB-500 without overthinking it.
11mBPC-157 and TB-500 are the most researched peptides for connective tissue repair—but combining them requires understanding their different mechanisms. Here's the complete stacking protocol based on actual user experience.
8mThe FDA's April 2026 announcement removed 12 peptides from Category 2 restrictions — the biggest regulatory shift in years. BPC-157, TB-500, MOTS-C, GHK-Cu, and Semax are among those affected. Here's what it actually means for your access.
7mWomen have unique considerations with peptides, from hormones and cycle changes to muscle retention, recovery, skin health, and tracking.
9mYou don't need to have diabetes to benefit from GLP-1 therapy. A comprehensive 2026 systematic review confirms what the peptide community has known for years — and the results are striking.
9mPsoriasis affects 125 million people worldwide. While peptides aren't a cure, emerging research suggests certain compounds may help calm inflammation and support skin repair. Here's what the science says.
9mAfter years of FDA crackdowns on research peptides, a significant regulatory reversal in 2026 has changed the landscape for BPC-157, TB-500, and MOTS-C. Here's what actually happened and what it means for you.
8mConfused about peptide compounding categories? This guide breaks down 503a compounding pharmacies, 503b outsourcing facilities, and why “research use only” is not a consumer pathway PeptIQ endorses.
8mFinished your GLP-1 cycle and want to maintain metabolic momentum? MOTS-C is one of the most effective peptides for supporting fat oxidation and energy during GLP-1 off-cycles. Here's how to dose and time it.
9mNo drug containing GHK-Cu is FDA approved. Topical copper peptides are cosmetics, non-injectable GHK-Cu is still under FDA evaluation, and GHK-Cu is not on the October 2026 HHS peptide list.
9mAlready on Reta and ready to add compounds? Here's how to stack Tesamorelin and MOTS-C with Retatrutide for maximum fat loss and recomp.
7mPeptide therapy searches on TikTok jumped 459% in early 2026. Here's what's driving the explosion, which peptides are trending, and what you need to know before you start.
9mAlready on tirzepatide and considering retatrutide? Here's exactly how to make the switch—starting doses based on your current Tirz level, what the glucagon component changes, and how to avoid common transition mistakes.
7mGrok says subQ Cerebrolysin doesn't work due to volumes. The real answer is more nuanced — and subQ is viable at research doses if you use the right solvent.
9mRunning Retatrutide and wondering what to add? This guide breaks down how MOTS-C, SS-31, AOD-9604, and SLU-PP-332 layer onto a GLP-1 protocol — and why they're not redundant.
9mFor years, GLP-1 therapy meant a weekly injection. The FDA just changed that. Foundayo is the first oral GLP-1 approved for weight management, and the implications for the peptide community go far beyond convenience.
6mBAC water works for most peptides. Acetic acid is for hydrophobic compounds that won't dissolve in BAC. Sterile water only for certain compounds like Cerebrolysin. Here's how to choose and troubleshoot.
9mThe FDA's April 15, 2026 reclassification of 12 research peptides marks the most significant regulatory shift in the space since the 2023 compounding crackdown. Here's a breakdown of the affected compounds, the new compliance landscape, and how to think about your protocol going forward.
10mMOTS-C activates AMPK and drives mitochondrial adaptation — but does daily use over months cause your body to stop responding? Here's what the research and user experience actually says about long-term MOTS-C protocols.
9mMost peptide users eventually ask: BAC or sterile water? This guide breaks down tradeoffs, timing, and practical decision rules with a peptide-by-peptide reference workflow.
10mAn FDA advisory panel scheduled for July 2026 could reshape access to 12 peptides — including BPC-157, MOTS-C, and GHK-Cu. Here's what's on the table, what reclassification would mean in practice, and how to prepare for either outcome.
10mEpitalon is a lab-made four-amino-acid peptide based on a pineal gland extract. It lengthens telomeres in cell studies, but human evidence is small and old. It is not FDA approved, and since October 2026 it is one of six peptides in an HHS compounding policy.
9mHitting a plateau on Retatrutide is common and usually temporary. Here's the science behind GLP-1 stalls and the practical steps to break through them.
8mSelank and Semax are two of the most powerful intranasal nootropic peptides available. Here's how they work, how they differ, and the best protocols for using them separately or stacked.
9mTwo products share the CJC-1295 name. Learn what the Drug Affinity Complex changes, what the 2006 human studies actually measured, and why the no-DAC version has far less published evidence.
10mBPC-157 and TB-500 are the two most evidence-backed peptides for structural tissue repair. For herniated disc recovery, they work through complementary pathways — here's how to stack them, dose them, and phase in the rest of a recovery protocol.
8mMost people who take NAD+ daily wonder whether they should cycle it. The answer isn't black and white — it depends on your dose, delivery method, and goals. Here's what the research and community experience actually suggest.
8mEpithalon is one of the most researched longevity peptides in existence, with decades of clinical data behind it. This guide covers the science of telomere elongation, dosing options, cycling protocols, and how it fits into a modern anti-aging stack.
8mA Stanford AI tool screened 2,600 uncharacterized peptides and identified BRP — a 12-amino acid molecule that cuts food intake by up to 50%, promotes fat burning, and avoids the nausea, constipation, and muscle loss common with GLP-1 drugs. Here's what the research actually shows.
10mMost peptide guides are written with a 35-year-old man in mind. If you're a woman in your 40s or 50s lifting hard and trying to recomp, the stack looks different. Here's what the research actually supports.
9mCerebrolysin is a brain-derived peptide mixture used for neuroprotection and cognitive enhancement. Here's what the research says, how to reconstitute it, and what real protocols look like.
7mMOTS-C is one of the most studied mitochondrial peptides for metabolic health and longevity. This guide covers dosing ranges, frequency, timing, stacking options, and what to track on protocol.
8mA complete breakdown of Dihexa — mechanism of action, dosing, what users actually report, and how it compares to Semax and Selank for cognitive enhancement.
9mDiscovered inside mitochondrial DNA itself, MOTS-c is one of the most fascinating longevity peptides in modern science. It governs how your cells produce energy, fight fat accumulation, and age.
6mOne of the most common beginner questions: can you draw multiple peptides into the same syringe? The answer depends on the combination. Here's the complete guide.
9mA potential FDA regulatory shift on 14 compounded peptides — including BPC-157 and TB-500 — could reshape who gets access to peptide therapy and how. Here's what the current signals actually mean.
8mNAD+ and peptides like BPC-157, MOTS-C, and KLOW work through completely different pathways — which is exactly why they stack well. Here's how to combine them safely and effectively.
10mThe biggest risk with GLP-1 weight loss drugs isn't the fat loss — it's the muscle you lose with it. Strategic peptide stacking can tip the balance toward true body recomposition.
9mEverything you need to know before your first retatrutide injection — reconstitution math, dose calculations, injection technique, and what to expect if you have prior GLP-1 sensitivity.
11mA 2026 meta-analysis comparing retatrutide to GLP-1 (Ozempic/Wegovy) and tirzepatide shows retatrutide delivers 28% superior fat loss. Here's the science behind why the triple-agonist approach is reshaping weight loss and body recomposition.
7mGHK-Cu is one of the most researched anti-aging peptides available. Here's a practical dosing guide covering protocols, cycle length, stacking, and what to realistically expect.
8mReconstituting peptides is simpler than it looks. This guide walks you through every step — from choosing the right BAC water volume to calculating units on your insulin syringe.
14mThe peptide space is shifting from weight loss toward longevity. Explore the science behind peptides designed to slow aging, repair cellular damage, and extend healthspan.
12mRetatrutide and tirzepatide dominate the peptide conversation, but they're not interchangeable. Here's what the latest clinical research reveals about their differences, efficacy, and mechanisms.
8mNew Phase 3 data shows retatrutide delivering superior metabolic benefits. Here's what researchers found and why it matters.
12mBPC-157 is the most versatile healing peptide available. Here's how it works and how to use it effectively.
12mGLP-1 agonists have revolutionized metabolic health. Learn how these peptides work, their effects on metabolism, and how to use them strategically for body composition goals.
18mFrom BPC-157 and GLP-1 agonists at the top to overhyped flops at the bottom — here's every major peptide ranked for 2026 across fat loss, skin, longevity, and recovery.
10mThe complete guide to safely reconstituting peptides, including dosage calculations and best practices.
9mExplore why Ipamorelin is considered the gentlest yet effective growth hormone releasing peptide available.
8mLearn where and how to inject peptides safely with our comprehensive injection site guide and rotation protocol.
Maximize your peptide investment with proper storage techniques that maintain potency and extend shelf life.
8mProtect yourself by learning how to verify peptide quality, understand testing reports, and avoid dangerous products.
11mDiscover which peptides work synergistically together and how to stack them safely for enhanced benefits.
7mUnderstand why bacteriostatic water is essential for peptide reconstitution and how to use it properly.
Discover the scientific foundation behind using GH peptides for anti-aging and longevity optimization.
7mLearn how to select the perfect insulin syringe for your peptide protocol with our comprehensive guide.
8mDiscover Tesamorelin, the only FDA-approved GHRH peptide, specifically indicated for reducing visceral fat.
7mLearn how to safely travel with your peptides while maintaining proper storage and navigating legal considerations.
Also available at /blog for legacy links.